Search

Author/Creator Tago, Fumitoshi

1. A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs. Issue 4 (4th July 2021)

Authors:
Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Journal:
Modern rheumatology
Issue:
Volume 31:Issue 4(2021)
Page Start:
783
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study. Issue 4 (18th February 2021)

Authors:
Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Journal:
Arthritis & rheumatology
Issue:
Volume 73:Issue 4(2021)
Page Start:
587
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll‐like Receptors 7 and 8, in Healthy Volunteers. Issue 4 (11th October 2022)

Authors:
Yamakawa, Naoto; Tago, Fumitoshi; Nakai, Kenya; Kitahara, Yasumi; Ikari, Shingo; Hojo, Seiichiro; Hall, Nancy; Aluri, Jagadeesh; Hussein, Ziad; Gevorkyan, Hakop; Maruyama, Tatsuya; Ishizaka, Sally; Yagi, Takuya
Journal:
Clinical pharmacology in drug development
Issue:
Volume 12:Issue 4(2023)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OP0223 EFFICACY AND SAFETY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS. (June 2019)

Authors:
Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. Issue 1 (2nd January 2018)

Authors:
Tanaka, Yoshiya; Takeuchi, Tsutomu; Umehara, Hisanori; Nanki, Toshihiro; Yasuda, Nobuyuki; Tago, Fumitoshi; Kawakubo, Makoto; Kitahara, Yasumi; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Journal:
Modern rheumatology
Issue:
Volume 28:Issue 1(2018)
Page Start:
58
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. SAT0126 A PHASE 2 STUDY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS INADEQUATELY RESPONDING TO BIOLOGICS. (June 2019)

Authors:
Tanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Hisaki, Hayato; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
1131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗